Revascularization is accomplished in 90–95% of CLI patients, according to current data. These findings indicate the increasing involvement of endovascular options (tibial angioplasty) in the last 5 years, indicated in the phrase "endovascular first" and often used in relativized indication. How long this more rigorous under-the-knee treatment will endure in a group of vascular patients with diabetes is uncertain. There is no reliable long-term evidence on how often and/or how quickly these patients need to be hospitalized to have their limbs amputated or CLI treatment. "10-30% of CLI patients can not be revascularized," most sources say.Vascular doctors require precise tools to analyze results to manage treatment for patients with limb-threatening ischemia. Historically, bypass-patency rates, amputation of larger limbs, and death were the most often used endpoints for measuring therapeutic efficacy. Because they're easy to recognize and document, they're important in clinical research. While more difficult to define and track, quality of life and functional status are more probable predictors of success.Amputation is not always necessary when standard revascularization is no longer an option for the patient, based on this paper's findings. Not every CLI patient is the same, and the effects of careful wound care alone in selected high-risk patients should not be overlooked. Also, some of the procedures/therapies discussed in this article may be appropriate for certain individuals. These techniques can be employed in patients with resting pain or non-healing wounds who have extensive minor artery disease, and no distal artery targets for standard open or endovascular revascularization, according to a literature review. As a reason, they are considered a last resort treatment when amputation seems to be the only plausible alternative decision. The hardest component of a vascular medicine specialist's work is to decide whether treatment is suitable for a given patient.